Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pathology and Oncology Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02904689PMID 9555115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proliferative (mib1, mdm2) versus anti-proliferative (p53) markers in head and neck cancer. An Immunohistochemical study

  2008cited by this paper
• nm23-H1 expression in squamous cell carcinoma of the head and neck

  2008cited by this paper
• Syndecan-1: a new prognostic marker in laryngeal cancer.

  1997cited by this paper
• WORKING EXPERIENCE WITH A NEW VACUUM‐ACCELERATED MICROWAVE HISTOPROCESSOR

  1996cited by this paper
• Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.

  1996cited by this paper
• Immunologic dysfunction in cancer.

  1996cited by this paper
• Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

  1996cited by this paper
• Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis

  1996cited by this paper
• The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.

  1996cited by this paper
• Biological staging of head and neck cancer and its role in developing effective treatment strategies

  1996cited by this paper
• Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.

  1996cited by this paper
• Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

  1995cited by this paper
• Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance

  1995cited by this paper
• Predicting Recurrence and Survival in Patients with Laryngeal Cancer by Means of DNA Cytometry, Tumor Front Grading, and Proliferation Markers

  1995cited by this paper
• Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis

  1993cited by this paper
• Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study.

  1993cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Cell-matrix interactions during tumor invasion

  1990cited by this paper
• Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.

  1989cited by this paper
• The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma

  1988cited by this paper
• Evidence for a novel gene associated with low tumor metastatic potential.

  1988cited by this paper

• Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors

  2022cites this paper
• Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival

  2020cites this paper
• Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance

  2014cites this paper
• Expression of excision repair cross-complementation group 1(ERCC1), ribonucleotide reductase M1 (RRM1) and class III beta-tubulin in head and neck carcinoma and its clinical significance

  2013cites this paper
• Expression of nm23H1 and MMP2 in laryngeal carcinoma and its role in aggressiveness of the tumour and node metastasis

  2013cites this paper
• CD44 Expression in Oro-Pharyngeal Carcinoma Tissues and Cell Lines

  2012cites this paper
• Cancer stem cells hypothesis and stem cells in head and neck cancers.

  2012cites this paper
• MMP-2 expression in 102 patients with glottic laryngeal cancer

  2012cites this paper
• CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma

  2011cites this paper
• Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization

  2011cites this paper
• Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites.

  2009cites this paper
• Expression of ERCC1, RRM1 and class III beta-tubulin in head and neck cancer and its clinical significance

  2008cites this paper
• BASIC SCIENCE REVIEW

  2007cites this paper
• Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization

  2005cites this paper
• Progression of head and neck squamous cell cancer

  2005cites this paper
• The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck

  2004cites this paper
• Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.

  2002cites this paper
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck

  2001cites this paper
• Progression Difference between Cancers of the Larynx and Hypopharynx is Not Due to Tumor Size and Vascularization

  2001cites this paper
• Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis

  2000cites this paper
• Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma.

  1999cites this paper